buyWeak cluster of 2
Powell Anderson Capital Partners LLC bought $232k of PMD
owner at PSYCHEMEDICS CORP. 86,991 shares at an average of $2.67, traded Dec 10, 2024, filed Dec 12, 2024.
Conviction score
34Value
$232k
86,991 shares
Holdings after
494,556
+21% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +12Role10% owner
- +13Trade size$232k at market
- +6Relative to holdingsHoldings up 21%
- 0Price contextNo price history yet
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001104659-24-128142, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 10, 2024 | POpen-market purchase Common Stockindirect: See footnote | +7,473 | $2.59 | $19k | 415,038 | Dec 12, 2024 |
| Dec 11, 2024 | POpen-market purchase Common Stockindirect: See footnote | +4,518 | $2.71 | $12k | 419,556 | Dec 12, 2024 |
| Dec 12, 2024 | POpen-market purchase Common Stockindirect: See footnote | +75,000 | $2.67 | $200k | 494,556 | Dec 12, 2024 |
Related signals
Other insiders at PSYCHEMEDICS CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 40Moderate | PSYCHEMEDICS CORP | Powell Anderson Capital Partners LLC owner | $305k 159,700 shares | +32% | |
| 42Moderate | PMDsell PSYCHEMEDICS CORP | Peter Kamin director, owner | $754k 320,708 shares | -18% | |
| 58Moderate | PSYCHEMEDICS CORP | Peter Kamin director, owner | $3.3M 1,409,712 shares | +343% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.